Thrombin-activatable Fibrinolysis Inhibitor (TAFI) as a Novel Prognostic Factor After Orthotropic Liver Transplantation: A Pilot Study

Abstract Background Thrombin-activatable fibrinolysis inhibitor (TAFI), a liver-produced coagulation factor, has been associated with higher mortality in cirrhotic patients, but there has not been any description of its role in perioperative care in liver transplantation cases. Methods A total of 21...

Full description

Bibliographic Details

Published in:	Transplantation proceedings Vol. 47; no. 6; pp. 1912 - 1914
Main Authors:	Nedel, W.L, Rodrigues Filho, E.M, Pasqualotto, A.C
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01-07-2015
Subjects:	Adult Biomarkers - metabolism Carboxypeptidase B2 - metabolism Female Humans Liver - metabolism Liver Cirrhosis - metabolism Liver Transplantation - methods Male Middle Aged Pilot Projects Prognosis Surgery
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!